APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Estrogen and Progesterone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Estrogen and Progesterone Market Analysis and Forecast 2026-2032

Report ID 173989800219 December 2025201 pages

Choose your research edition.

Industry ResearchEstrogen and Progesterone Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Estrogen and Progesterone Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Estrogen and Progesterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estrogen and Progesterone Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Estrogen and Progesterone Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Estrogen and Progesterone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Estrogen and Progesterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Estrogen and Progesterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Estrogen and Progesterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Estrogen and Progesterone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Estrogen and Progesterone include Aspen Pharmacare, Besins Healthcare, Dr.Kade Pharmazeutische Fabrik, F.I.S.-FABBRICA, Gedeon Richter, Jenapharm, MERCK SERONO, N.V.Organon and Novartis Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Estrogen and Progesterone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Estrogen and Progesterone, also provides the sales of main regions and countries. Of the upcoming market potential for Estrogen and Progesterone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Estrogen and Progesterone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Estrogen and Progesterone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Estrogen and Progesterone sales, projected growth trends, production technology, application and end-user industry.

Estrogen and Progesterone Segment by Company

Aspen Pharmacare

Besins Healthcare

Dr.Kade Pharmazeutische Fabrik

F.I.S.-FABBRICA

Gedeon Richter

Jenapharm

MERCK SERONO

N.V.Organon

Novartis Pharma

Orion

Pfizer Healthcare

Teva Pharma

AstraZeneca

Bayer

Eli Lilly

Novo Nordisk

Abbott

Estrogen and Progesterone Segment by Type

Estrogen

Progesterone

Estrogen and Progesterone Segment by Application

Hospital

Pharmacy

Department of Endocrinology

Estrogen and Progesterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estrogen and Progesterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estrogen and Progesterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estrogen and Progesterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Estrogen and Progesterone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Estrogen and Progesterone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Estrogen and Progesterone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Estrogen Major Manufacturers Table 3. Progesterone Major Manufacturers Table 4. Global Estrogen and Progesterone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Department of Endocrinology Major Manufacturers Table 8. Estrogen and Progesterone Industry Trends Table 9. Estrogen and Progesterone Industry Drivers Table 10. Estrogen and Progesterone Industry Opportunities and Challenges Table 11. Estrogen and Progesterone Industry Restraints Table 12. Global Estrogen and Progesterone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Estrogen and Progesterone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Estrogen and Progesterone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Estrogen and Progesterone Revenue Market Share by Region (2021-2026) Table 16. Global Estrogen and Progesterone Revenue Market Share by Region (2027-2032) Table 17. Global Estrogen and Progesterone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Estrogen and Progesterone Sales by Region (2021-2026) & (K Units) Table 19. Global Estrogen and Progesterone Sales by Region (2027-2032) & (K Units) Table 20. Global Estrogen and Progesterone Sales Market Share by Region (2021-2026) Table 21. Global Estrogen and Progesterone Sales Market Share by Region (2027-2032) Table 22. Global Estrogen and Progesterone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Estrogen and Progesterone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Estrogen and Progesterone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Estrogen and Progesterone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Estrogen and Progesterone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Estrogen and Progesterone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Estrogen and Progesterone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Estrogen and Progesterone Manufacturers, Product Type & Application Table 30. Global Estrogen and Progesterone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Estrogen and Progesterone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Estrogen and Progesterone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2026) Table 37. Global Estrogen and Progesterone Revenue Market Share by Type (2027-2032) Table 38. Global Estrogen and Progesterone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 40. Global Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 41. Global Estrogen and Progesterone Sales Market Share by Type (2021-2026) Table 42. Global Estrogen and Progesterone Sales Market Share by Type (2027-2032) Table 43. Global Estrogen and Progesterone Price by Type (2021-2026) & (US$/Unit) Table 44. Global Estrogen and Progesterone Price by Type (2027-2032) & (US$/Unit) Table 45. Global Estrogen and Progesterone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2026) Table 49. Global Estrogen and Progesterone Revenue Market Share by Application (2027-2032) Table 50. Global Estrogen and Progesterone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 52. Global Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 53. Global Estrogen and Progesterone Sales Market Share by Application (2021-2026) Table 54. Global Estrogen and Progesterone Sales Market Share by Application (2027-2032) Table 55. Global Estrogen and Progesterone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Estrogen and Progesterone Price by Application (2027-2032) & (US$/Unit) Table 57. Aspen Pharmacare Company Information Table 58. Aspen Pharmacare Business Overview Table 59. Aspen Pharmacare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Aspen Pharmacare Estrogen and Progesterone Product Portfolio Table 61. Aspen Pharmacare Recent Development Table 62. Besins Healthcare Company Information Table 63. Besins Healthcare Business Overview Table 64. Besins Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Besins Healthcare Estrogen and Progesterone Product Portfolio Table 66. Besins Healthcare Recent Development Table 67. Dr.Kade Pharmazeutische Fabrik Company Information Table 68. Dr.Kade Pharmazeutische Fabrik Business Overview Table 69. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio Table 71. Dr.Kade Pharmazeutische Fabrik Recent Development Table 72. F.I.S.-FABBRICA Company Information Table 73. F.I.S.-FABBRICA Business Overview Table 74. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio Table 76. F.I.S.-FABBRICA Recent Development Table 77. Gedeon Richter Company Information Table 78. Gedeon Richter Business Overview Table 79. Gedeon Richter Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Gedeon Richter Estrogen and Progesterone Product Portfolio Table 81. Gedeon Richter Recent Development Table 82. Jenapharm Company Information Table 83. Jenapharm Business Overview Table 84. Jenapharm Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jenapharm Estrogen and Progesterone Product Portfolio Table 86. Jenapharm Recent Development Table 87. MERCK SERONO Company Information Table 88. MERCK SERONO Business Overview Table 89. MERCK SERONO Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. MERCK SERONO Estrogen and Progesterone Product Portfolio Table 91. MERCK SERONO Recent Development Table 92. N.V.Organon Company Information Table 93. N.V.Organon Business Overview Table 94. N.V.Organon Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. N.V.Organon Estrogen and Progesterone Product Portfolio Table 96. N.V.Organon Recent Development Table 97. Novartis Pharma Company Information Table 98. Novartis Pharma Business Overview Table 99. Novartis Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis Pharma Estrogen and Progesterone Product Portfolio Table 101. Novartis Pharma Recent Development Table 102. Orion Company Information Table 103. Orion Business Overview Table 104. Orion Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Orion Estrogen and Progesterone Product Portfolio Table 106. Orion Recent Development Table 107. Pfizer Healthcare Company Information Table 108. Pfizer Healthcare Business Overview Table 109. Pfizer Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Healthcare Estrogen and Progesterone Product Portfolio Table 111. Pfizer Healthcare Recent Development Table 112. Teva Pharma Company Information Table 113. Teva Pharma Business Overview Table 114. Teva Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Teva Pharma Estrogen and Progesterone Product Portfolio Table 116. Teva Pharma Recent Development Table 117. AstraZeneca Company Information Table 118. AstraZeneca Business Overview Table 119. AstraZeneca Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AstraZeneca Estrogen and Progesterone Product Portfolio Table 121. AstraZeneca Recent Development Table 122. Bayer Company Information Table 123. Bayer Business Overview Table 124. Bayer Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Bayer Estrogen and Progesterone Product Portfolio Table 126. Bayer Recent Development Table 127. Eli Lilly Company Information Table 128. Eli Lilly Business Overview Table 129. Eli Lilly Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Eli Lilly Estrogen and Progesterone Product Portfolio Table 131. Eli Lilly Recent Development Table 132. Novo Nordisk Company Information Table 133. Novo Nordisk Business Overview Table 134. Novo Nordisk Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Novo Nordisk Estrogen and Progesterone Product Portfolio Table 136. Novo Nordisk Recent Development Table 137. Abbott Company Information Table 138. Abbott Business Overview Table 139. Abbott Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Abbott Estrogen and Progesterone Product Portfolio Table 141. Abbott Recent Development Table 142. North America Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 145. North America Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 146. North America Estrogen and Progesterone Sales Price by Type (2021-2026) & (US$/Unit) Table 147. North America Estrogen and Progesterone Sales Price by Type (2027-2032) & (US$/Unit) Table 148. North America Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 151. North America Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 152. North America Estrogen and Progesterone Sales Price by Application (2021-2026) & (US$/Unit) Table 153. North America Estrogen and Progesterone Sales Price by Application (2027-2032) & (US$/Unit) Table 154. North America Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Estrogen and Progesterone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Estrogen and Progesterone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. North America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 159. North America Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 160. North America Estrogen and Progesterone Sales Price by Country (2021-2026) & (US$/Unit) Table 161. North America Estrogen and Progesterone Sales Price by Country (2027-2032) & (US$/Unit) Table 162. United States Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 163. Canada Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 164. Europe Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 167. Europe Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 168. Europe Estrogen and Progesterone Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe Estrogen and Progesterone Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 173. Europe Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 174. Europe Estrogen and Progesterone Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe Estrogen and Progesterone Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Estrogen and Progesterone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Estrogen and Progesterone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Europe Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 181. Europe Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 182. Europe Estrogen and Progesterone Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe Estrogen and Progesterone Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 185. France Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 186. U.K. Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 187. Italy Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 188. Netherlands Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 189. Nordic Countries Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 190. China Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 191. China Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 192. China Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 193. China Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 194. China Estrogen and Progesterone Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Estrogen and Progesterone Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 197. China Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 198. China Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 199. China Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 200. China Estrogen and Progesterone Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Estrogen and Progesterone Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 205. Asia Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 206. Asia Estrogen and Progesterone Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Estrogen and Progesterone Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 211. Asia Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 212. Asia Estrogen and Progesterone Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Estrogen and Progesterone Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Estrogen and Progesterone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Estrogen and Progesterone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. Asia Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 219. Asia Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 220. Asia Estrogen and Progesterone Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Estrogen and Progesterone Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 223. South Korea Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 224. India Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 225. Australia Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 226. China Taiwan Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 231. SAMEA Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 232. SAMEA Estrogen and Progesterone Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Estrogen and Progesterone Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 237. SAMEA Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 238. SAMEA Estrogen and Progesterone Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Estrogen and Progesterone Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Estrogen and Progesterone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Estrogen and Progesterone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. SAMEA Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 245. SAMEA Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 246. SAMEA Estrogen and Progesterone Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Estrogen and Progesterone Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 249. Argentina Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 250. Chile Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 251. Colombia Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 252. Peru Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 254. Israel Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 255. UAE Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 256. Turkey Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 257. Iran Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 258. Egypt Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Estrogen and Progesterone Distributors List Table 262. Estrogen and Progesterone Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Estrogen and Progesterone Image Figure 2. Global Estrogen and Progesterone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estrogen and Progesterone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Estrogen Image Figure 5. Progesterone Image Figure 6. Global Estrogen and Progesterone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Estrogen and Progesterone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Department of Endocrinology Image Figure 11. Global Estrogen and Progesterone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Figure 13. Global Estrogen and Progesterone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Estrogen and Progesterone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Estrogen and Progesterone Revenue Market Share by Region (2021-2032) Figure 16. Global Estrogen and Progesterone Sales (2021-2032) & (K Units) Figure 17. Global Estrogen and Progesterone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Estrogen and Progesterone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Estrogen and Progesterone Sales YoY (2021-2032) & (K Units) Figure 20. Europe Estrogen and Progesterone Sales YoY (2021-2032) & (K Units) Figure 21. China Estrogen and Progesterone Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Estrogen and Progesterone Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Estrogen and Progesterone Sales YoY (2021-2032) & (K Units) Figure 24. Global Estrogen and Progesterone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Estrogen and Progesterone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Estrogen and Progesterone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Estrogen and Progesterone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032) Figure 30. Global Estrogen and Progesterone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Estrogen and Progesterone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Estrogen and Progesterone Sales Market Share by Type (2021-2032) Figure 33. Global Estrogen and Progesterone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Estrogen and Progesterone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032) Figure 36. Global Estrogen and Progesterone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Estrogen and Progesterone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Estrogen and Progesterone Sales Market Share by Application (2021-2032) Figure 39. North America Estrogen and Progesterone Revenue Share by Type (2021-2032) Figure 40. North America Estrogen and Progesterone Sales Share by Type (2021-2032) Figure 41. North America Estrogen and Progesterone Revenue Share by Application (2021-2032) Figure 42. North America Estrogen and Progesterone Sales Share by Application (2021-2032) Figure 43. North America Estrogen and Progesterone Revenue Share by Country (2021-2032) Figure 44. North America Estrogen and Progesterone Sales Share by Country (2021-2032) Figure 45. Europe Estrogen and Progesterone Revenue Share by Type (2021-2032) Figure 46. Europe Estrogen and Progesterone Sales Share by Type (2021-2032) Figure 47. Europe Estrogen and Progesterone Revenue Share by Application (2021-2032) Figure 48. Europe Estrogen and Progesterone Sales Share by Application (2021-2032) Figure 49. Europe Estrogen and Progesterone Revenue Share by Country (2021-2032) Figure 50. Europe Estrogen and Progesterone Sales Share by Country (2021-2032) Figure 51. China Estrogen and Progesterone Revenue Share by Type (2021-2032) Figure 52. China Estrogen and Progesterone Sales Share by Type (2021-2032) Figure 53. China Estrogen and Progesterone Revenue Share by Application (2021-2032) Figure 54. China Estrogen and Progesterone Sales Share by Application (2021-2032) Figure 55. Asia Estrogen and Progesterone Revenue Share by Type (2021-2032) Figure 56. Asia Estrogen and Progesterone Sales Share by Type (2021-2032) Figure 57. Asia Estrogen and Progesterone Revenue Share by Application (2021-2032) Figure 58. Asia Estrogen and Progesterone Sales Share by Application (2021-2032) Figure 59. Asia Estrogen and Progesterone Revenue Share by Country (2021-2032) Figure 60. Asia Estrogen and Progesterone Sales Share by Country (2021-2032) Figure 61. SAMEA Estrogen and Progesterone Revenue Share by Type (2021-2032) Figure 62. SAMEA Estrogen and Progesterone Sales Share by Type (2021-2032) Figure 63. SAMEA Estrogen and Progesterone Revenue Share by Application (2021-2032) Figure 64. SAMEA Estrogen and Progesterone Sales Share by Application (2021-2032) Figure 65. SAMEA Estrogen and Progesterone Revenue Share by Country (2021-2032) Figure 66. SAMEA Estrogen and Progesterone Sales Share by Country (2021-2032) Figure 67. Estrogen and Progesterone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Estrogen and Progesterone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogen
  • Progesterone
Applications
  • Hospital
  • Pharmacy
  • Department of Endocrinology
Companies covered
  • Aspen Pharmacare
  • Besins Healthcare
  • Dr.Kade Pharmazeutische Fabrik
  • F.I.S.-FABBRICA
  • Gedeon Richter
  • Jenapharm
  • MERCK SERONO
  • N.V.Organon
  • Novartis Pharma
  • Orion
  • Pfizer Healthcare
  • Teva Pharma
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Novo Nordisk
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Estrogen and Progesterone Market by Type
  3. 1.2.1 Global Estrogen and Progesterone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Estrogen
  5. 1.2.3 Progesterone
  6. 1.3 Estrogen and Progesterone Market by Application
  7. 1.3.1 Global Estrogen and Progesterone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.3.4 Department of Endocrinology
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Estrogen and Progesterone Market Dynamics
  1. 2.1 Estrogen and Progesterone Industry Trends
  2. 2.2 Estrogen and Progesterone Industry Drivers
  3. 2.3 Estrogen and Progesterone Industry Opportunities and Challenges
  4. 2.4 Estrogen and Progesterone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Estrogen and Progesterone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Estrogen and Progesterone Revenue by Region
  3. 3.2.1 Global Estrogen and Progesterone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Estrogen and Progesterone Revenue by Region (2021-2026)
  5. 3.2.3 Global Estrogen and Progesterone Revenue by Region (2027-2032)
  6. 3.2.4 Global Estrogen and Progesterone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Estrogen and Progesterone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Estrogen and Progesterone Sales by Region
  9. 3.4.1 Global Estrogen and Progesterone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Estrogen and Progesterone Sales by Region (2021-2026)
  11. 3.4.3 Global Estrogen and Progesterone Sales by Region (2027-2032)
  12. 3.4.4 Global Estrogen and Progesterone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Estrogen and Progesterone Revenue by Manufacturers
  2. 4.1.1 Global Estrogen and Progesterone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Estrogen and Progesterone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Estrogen and Progesterone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Estrogen and Progesterone Sales by Manufacturers
  6. 4.2.1 Global Estrogen and Progesterone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Estrogen and Progesterone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Estrogen and Progesterone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Estrogen and Progesterone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Estrogen and Progesterone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Estrogen and Progesterone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Estrogen and Progesterone Manufacturers, Product Type & Application
  13. 4.7 Global Estrogen and Progesterone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Estrogen and Progesterone Market CR5 and HHI
  16. 4.8.2 2025 Estrogen and Progesterone Tier 1, Tier 2, and Tier 3
5 Estrogen and Progesterone Market by Type
  1. 5.1 Global Estrogen and Progesterone Revenue by Type
  2. 5.1.1 Global Estrogen and Progesterone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Estrogen and Progesterone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Estrogen and Progesterone Sales by Type
  6. 5.2.1 Global Estrogen and Progesterone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Estrogen and Progesterone Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Estrogen and Progesterone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Estrogen and Progesterone Price by Type
6 Estrogen and Progesterone Market by Application
  1. 6.1 Global Estrogen and Progesterone Revenue by Application
  2. 6.1.1 Global Estrogen and Progesterone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Estrogen and Progesterone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Estrogen and Progesterone Sales by Application
  6. 6.2.1 Global Estrogen and Progesterone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Estrogen and Progesterone Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Estrogen and Progesterone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Estrogen and Progesterone Price by Application
7 Company Profiles
  1. 7.1 Aspen Pharmacare
  2. 7.1.1 Aspen Pharmacare Company Information
  3. 7.1.2 Aspen Pharmacare Business Overview
  4. 7.1.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aspen Pharmacare Estrogen and Progesterone Product Portfolio
  6. 7.1.5 Aspen Pharmacare Recent Developments
  7. 7.2 Besins Healthcare
  8. 7.2.1 Besins Healthcare Company Information
  9. 7.2.2 Besins Healthcare Business Overview
  10. 7.2.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Besins Healthcare Estrogen and Progesterone Product Portfolio
  12. 7.2.5 Besins Healthcare Recent Developments
  13. 7.3 Dr.Kade Pharmazeutische Fabrik
  14. 7.3.1 Dr.Kade Pharmazeutische Fabrik Company Information
  15. 7.3.2 Dr.Kade Pharmazeutische Fabrik Business Overview
  16. 7.3.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio
  18. 7.3.5 Dr.Kade Pharmazeutische Fabrik Recent Developments
  19. 7.4 F.I.S.-FABBRICA
  20. 7.4.1 F.I.S.-FABBRICA Company Information
  21. 7.4.2 F.I.S.-FABBRICA Business Overview
  22. 7.4.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio
  24. 7.4.5 F.I.S.-FABBRICA Recent Developments
  25. 7.5 Gedeon Richter
  26. 7.5.1 Gedeon Richter Company Information
  27. 7.5.2 Gedeon Richter Business Overview
  28. 7.5.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gedeon Richter Estrogen and Progesterone Product Portfolio
  30. 7.5.5 Gedeon Richter Recent Developments
  31. 7.6 Jenapharm
  32. 7.6.1 Jenapharm Company Information
  33. 7.6.2 Jenapharm Business Overview
  34. 7.6.3 Jenapharm Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jenapharm Estrogen and Progesterone Product Portfolio
  36. 7.6.5 Jenapharm Recent Developments
  37. 7.7 MERCK SERONO
  38. 7.7.1 MERCK SERONO Company Information
  39. 7.7.2 MERCK SERONO Business Overview
  40. 7.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MERCK SERONO Estrogen and Progesterone Product Portfolio
  42. 7.7.5 MERCK SERONO Recent Developments
  43. 7.8 N.V.Organon
  44. 7.8.1 N.V.Organon Company Information
  45. 7.8.2 N.V.Organon Business Overview
  46. 7.8.3 N.V.Organon Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 N.V.Organon Estrogen and Progesterone Product Portfolio
  48. 7.8.5 N.V.Organon Recent Developments
  49. 7.9 Novartis Pharma
  50. 7.9.1 Novartis Pharma Company Information
  51. 7.9.2 Novartis Pharma Business Overview
  52. 7.9.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Novartis Pharma Estrogen and Progesterone Product Portfolio
  54. 7.9.5 Novartis Pharma Recent Developments
  55. 7.10 Orion
  56. 7.10.1 Orion Company Information
  57. 7.10.2 Orion Business Overview
  58. 7.10.3 Orion Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Orion Estrogen and Progesterone Product Portfolio
  60. 7.10.5 Orion Recent Developments
  61. 7.11 Pfizer Healthcare
  62. 7.11.1 Pfizer Healthcare Company Information
  63. 7.11.2 Pfizer Healthcare Business Overview
  64. 7.11.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pfizer Healthcare Estrogen and Progesterone Product Portfolio
  66. 7.11.5 Pfizer Healthcare Recent Developments
  67. 7.12 Teva Pharma
  68. 7.12.1 Teva Pharma Company Information
  69. 7.12.2 Teva Pharma Business Overview
  70. 7.12.3 Teva Pharma Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Teva Pharma Estrogen and Progesterone Product Portfolio
  72. 7.12.5 Teva Pharma Recent Developments
  73. 7.13 AstraZeneca
  74. 7.13.1 AstraZeneca Company Information
  75. 7.13.2 AstraZeneca Business Overview
  76. 7.13.3 AstraZeneca Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 AstraZeneca Estrogen and Progesterone Product Portfolio
  78. 7.13.5 AstraZeneca Recent Developments
  79. 7.14 Bayer
  80. 7.14.1 Bayer Company Information
  81. 7.14.2 Bayer Business Overview
  82. 7.14.3 Bayer Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bayer Estrogen and Progesterone Product Portfolio
  84. 7.14.5 Bayer Recent Developments
  85. 7.15 Eli Lilly
  86. 7.15.1 Eli Lilly Company Information
  87. 7.15.2 Eli Lilly Business Overview
  88. 7.15.3 Eli Lilly Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Eli Lilly Estrogen and Progesterone Product Portfolio
  90. 7.15.5 Eli Lilly Recent Developments
  91. 7.16 Novo Nordisk
  92. 7.16.1 Novo Nordisk Company Information
  93. 7.16.2 Novo Nordisk Business Overview
  94. 7.16.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Novo Nordisk Estrogen and Progesterone Product Portfolio
  96. 7.16.5 Novo Nordisk Recent Developments
  97. 7.17 Abbott
  98. 7.17.1 Abbott Company Information
  99. 7.17.2 Abbott Business Overview
  100. 7.17.3 Abbott Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abbott Estrogen and Progesterone Product Portfolio
  102. 7.17.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Estrogen and Progesterone Market Size by Type
  2. 8.1.1 North America Estrogen and Progesterone Revenue by Type (2021-2032)
  3. 8.1.2 North America Estrogen and Progesterone Sales by Type (2021-2032)
  4. 8.1.3 North America Estrogen and Progesterone Price by Type (2021-2032)
  5. 8.2 North America Estrogen and Progesterone Market Size by Application
  6. 8.2.1 North America Estrogen and Progesterone Revenue by Application (2021-2032)
  7. 8.2.2 North America Estrogen and Progesterone Sales by Application (2021-2032)
  8. 8.2.3 North America Estrogen and Progesterone Price by Application (2021-2032)
  9. 8.3 North America Estrogen and Progesterone Market Size by Country
  10. 8.3.1 North America Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Estrogen and Progesterone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Estrogen and Progesterone Market Size by Type
  2. 9.1.1 Europe Estrogen and Progesterone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Estrogen and Progesterone Sales by Type (2021-2032)
  4. 9.1.3 Europe Estrogen and Progesterone Price by Type (2021-2032)
  5. 9.2 Europe Estrogen and Progesterone Market Size by Application
  6. 9.2.1 Europe Estrogen and Progesterone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Estrogen and Progesterone Sales by Application (2021-2032)
  8. 9.2.3 Europe Estrogen and Progesterone Price by Application (2021-2032)
  9. 9.3 Europe Estrogen and Progesterone Market Size by Country
  10. 9.3.1 Europe Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Estrogen and Progesterone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Estrogen and Progesterone Market Size by Type
  2. 10.1.1 China Estrogen and Progesterone Revenue by Type (2021-2032)
  3. 10.1.2 China Estrogen and Progesterone Sales by Type (2021-2032)
  4. 10.1.3 China Estrogen and Progesterone Price by Type (2021-2032)
  5. 10.2 China Estrogen and Progesterone Market Size by Application
  6. 10.2.1 China Estrogen and Progesterone Revenue by Application (2021-2032)
  7. 10.2.2 China Estrogen and Progesterone Sales by Application (2021-2032)
  8. 10.2.3 China Estrogen and Progesterone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Estrogen and Progesterone Market Size by Type
  2. 11.1.1 Asia Estrogen and Progesterone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Estrogen and Progesterone Sales by Type (2021-2032)
  4. 11.1.3 Asia Estrogen and Progesterone Price by Type (2021-2032)
  5. 11.2 Asia Estrogen and Progesterone Market Size by Application
  6. 11.2.1 Asia Estrogen and Progesterone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Estrogen and Progesterone Sales by Application (2021-2032)
  8. 11.2.3 Asia Estrogen and Progesterone Price by Application (2021-2032)
  9. 11.3 Asia Estrogen and Progesterone Market Size by Country
  10. 11.3.1 Asia Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Estrogen and Progesterone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Estrogen and Progesterone Market Size by Type
  2. 12.1.1 SAMEA Estrogen and Progesterone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Estrogen and Progesterone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Estrogen and Progesterone Price by Type (2021-2032)
  5. 12.2 SAMEA Estrogen and Progesterone Market Size by Application
  6. 12.2.1 SAMEA Estrogen and Progesterone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Estrogen and Progesterone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Estrogen and Progesterone Price by Application (2021-2032)
  9. 12.3 SAMEA Estrogen and Progesterone Market Size by Country
  10. 12.3.1 SAMEA Estrogen and Progesterone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Estrogen and Progesterone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Estrogen and Progesterone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Estrogen and Progesterone Value Chain Analysis
  2. 13.1.1 Estrogen and Progesterone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Estrogen and Progesterone Production Mode & Process
  6. 13.2 Estrogen and Progesterone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Estrogen and Progesterone Distributors
  9. 13.2.3 Estrogen and Progesterone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst